Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Tamminga, CA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 193 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Medoff, DR; Holcomb, HH; Lahti, AC; Tamminga, CA
      Probing the human hippocampus using rCBF: Contrasts in schizophrenia

      HIPPOCAMPUS
    2. Tamminga, CA; Schulz, SC
      Special issue - Abstracts of the VIITH International Congress on Schizophrenia Research - British Columbia, Canada - April 28-May 2, 2001

      SCHIZOPHRENIA RESEARCH
    3. Lahti, AC; Weiler, MA; Michaelidis, T; Parwani, A; Tamminga, CA
      Effects of ketamine in normal and schizophrenic volunteers

      NEUROPSYCHOPHARMACOLOGY
    4. Holcomb, HH; Lahti, AC; Medoff, DR; Weiler, M; Tamminga, CA
      Sequential regional cerebral blood flow brain scans using PET with (H2O)-O-15 demonstrate ketamine actions in CNS dynamically

      NEUROPSYCHOPHARMACOLOGY
    5. Sakai, K; Gao, XM; Hashimoto, T; Tamminga, CA
      Traditional and new antipsychotic drugs differentially alter neurotransmission markers in basal ganglia-thalamocortical neural pathways

      SYNAPSE
    6. Tamminga, CA
      Introduction - Evaluating clinical trial data from schizophrenia research

      JOURNAL OF CLINICAL PSYCHIATRY
    7. Dwivedi, Y; Rizavi, HS; Roberts, RC; Conley, RC; Tamminga, CA; Pandey, GN
      Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects

      JOURNAL OF NEUROCHEMISTRY
    8. Schwarcz, R; Rassoulpour, A; Wu, HQ; Medoff, D; Tamminga, CA; Roberts, RC
      Increased cortical kynurenate content in schizophrenia

      BIOLOGICAL PSYCHIATRY
    9. Lahti, AC; Warfel, D; Michaelidis, T; Weiler, MA; Frey, K; Tamminga, CA
      Long-term outcome of patients who receive ketamine during research

      BIOLOGICAL PSYCHIATRY
    10. Tamminga, CA; Frost, DO
      Changing concepts in the neurochemistry of schizophrenia

      AMERICAN JOURNAL OF PSYCHIATRY
    11. Mirnics, K; Middleton, FA; Lewis, DA; Levitt, P; Tamminga, CA
      The human genome

      AMERICAN JOURNAL OF PSYCHIATRY
    12. Brockman, JA; Tamminga, CA
      The human genome

      AMERICAN JOURNAL OF PSYCHIATRY
    13. Tamminga, CA
      The human genome

      AMERICAN JOURNAL OF PSYCHIATRY
    14. Tamminga, CA
      The human genome

      AMERICAN JOURNAL OF PSYCHIATRY
    15. Tamminga, CA
      The human genome sequence

      AMERICAN JOURNAL OF PSYCHIATRY
    16. Tamminga, CA; Holcomb, HH
      Neural networks - Neural systems VI: Basal ganglia

      AMERICAN JOURNAL OF PSYCHIATRY
    17. Lahti, AC; Holcomb, HH; Medoff, DR; Weiler, MA; Tamminga, CA; Carpenter, WT
      Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task

      AMERICAN JOURNAL OF PSYCHIATRY
    18. Sakai, K; Gao, XM; Tamminga, CA
      Scopolamine fails to diminish chronic haloperidol-induced purposeless chewing in rats

      PSYCHOPHARMACOLOGY
    19. Weiler, MA; Thaker, GK; Lahti, AC; Tamminga, CA
      Ketamine effects on eye movements

      NEUROPSYCHOPHARMACOLOGY
    20. Buckley, PF; Buchanan, RW; Tamminga, CA; Schulz, SC
      Schizophrenia research: A progress report, summarizing proceedings of the 1999 International Congress on Schizophrenia Research

      SCHIZOPHRENIA BULLETIN
    21. Tamminga, CA; Vogel, M; Cao, XM; Lahti, AC; Holcomb, HH
      The limbic cortex in schizophrenia: focus on the anterior cingulate

      BRAIN RESEARCH REVIEWS
    22. Gao, XM; Sakai, K; Roberts, RC; Conley, RR; Dean, B; Tamminga, CA
      Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: Effects of schizophrenia

      AMERICAN JOURNAL OF PSYCHIATRY
    23. Holcomb, HH; Lahti, AC; Medoff, DR; Weiler, M; Dannals, RF; Tamminga, CA
      Brain activation patterns in schizophrenic and comparison volunteers during a matched-performance auditory recognition task

      AMERICAN JOURNAL OF PSYCHIATRY
    24. Tamminga, CA
      "New" rather than "atypical"

      PSYCHOPHARMACOLOGY
    25. Holcomb, HH; Medoff, DR; Lahti, AC; Tamminga, CA
      Functional neuroimaging in schizophrenia: Symptoms, treatment, and etiology

      SCHIZOPHRENIA IN A MOLECULAR AGE
    26. Kelly, DL; Conley, RR; Tamminga, CA
      Differential olanzapine plasma concentrations by sex in a fixed-dose study

      SCHIZOPHRENIA RESEARCH
    27. Lahti, AC; Holcomb, HH; Gao, XM; Tamminga, CA
      NMDA-sensitive glutamate antagonism: a human model for psychosis

      NEUROPSYCHOPHARMACOLOGY
    28. Lahti, RA; Tamminga, CA
      Effect of amphetamine, alpha-methyl-p-tyrosine (alpha-MPT) and antipsychotic agents on dopamine D-2-type receptor occupancy in rats

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    29. Tamminga, CA
      Neuroscience and schizophrenia

      BIOLOGICAL PSYCHIATRY
    30. Tamminga, CA; Lieberman, JA
      Schizophrenia research series: From molecule to public policy

      BIOLOGICAL PSYCHIATRY
    31. Conley, RR; Tamminga, CA; Kelly, DL; Richardson, CM
      Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response

      BIOLOGICAL PSYCHIATRY
    32. Tamminga, CA
      Images in neuroscience - Cognition: Perception, 2

      AMERICAN JOURNAL OF PSYCHIATRY
    33. Tamminga, CA
      Cognition - Perception, I

      AMERICAN JOURNAL OF PSYCHIATRY
    34. Truffinet, P; Tamminga, CA; Fabre, LF; Meltzer, HY; Riviere, ME; Papillon-Downey, C
      Placebo-controlled study of the D-4/5-HT2A antagonist fananserin in the treatment of schizophrenia

      AMERICAN JOURNAL OF PSYCHIATRY
    35. Pandey, GN; Dwivedi, Y; Pandey, SC; Teas, SS; Conley, RR; Roberts, RC; Tamminga, CA
      Low phosphoinositide-specific phospholipase C activity and expression of phospholipase C beta(1) protein in the prefrontal cortex of teenage suicide subjects

      AMERICAN JOURNAL OF PSYCHIATRY
    36. LAHTI RA; ROBERTS RC; COCHRANE EV; PRIMUS RJ; GALLAGER DW; CONLEY RR; TAMMINGA CA
      DIRECT DETERMINATION OF DOPAMINE D-4 RECEPTORS IN NORMAL AND SCHIZOPHRENIC POSTMORTEM BRAIN-TISSUE - A [H-3]NGD-94-1 STUDY

      Molecular psychiatry
    37. HOLCOMB HH; MEDOFF DR; CAUDILL PJ; ZHAO Z; LAHTI AC; DANNALS RF; TAMMINGA CA
      CEREBRAL BLOOD-FLOW RELATIONSHIPS ASSOCIATED WITH A DIFFICULT TONE RECOGNITION TASK IN TRAINED NORMAL VOLUNTEERS

      Cerebral cortex (New York, N.Y. 1991)
    38. LAHTI AC; CHEN LW; WARFEL D; COREY PK; BARTKO J; TAMMINGA CA
      THE FACTOR STRUCTURE FOR PSYCHOTIC SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA OVER 3 CLINICAL STATES

      Schizophrenia research
    39. LAHTI RA; ROBERTS RC; COCHRANE EV; PRIMUS RJ; GALLAGER DW; TAMMINGA CA
      DOPAMINE D-4 RECEPTORS IN HUMAN POSTMORTEM BRAIN-TISSUE OF NORMAL ANDSCHIZOPHRENIC SUBJECTS, AN [(3)]NGD-94-1 STUDY

      Schizophrenia research
    40. LAHTI AC; HOLCOMB HH; WEILER MA; MEDOFF D; TAMMINGA CA
      TIME-COURSE OF RCBF CHANGES AFTER ACUTE HALOPERIDOL IN PATIENTS WITH SCHIZOPHRENIA

      Schizophrenia research
    41. GAO XM; SAKAI K; TAMMINGA CA
      CHRONIC OLANZAPINE OR SERTINDOLE TREATMENT RESULTS IN REDUCED ORAL CHEWING MOVEMENTS IN RATS COMPARED TO HALOPERIDOL

      Neuropsychopharmacology
    42. TAMMINGA CA
      SCHIZOPHRENIA AND GLUTAMATERGIC TRANSMISSION

      Critical reviews in neurobiology
    43. GAO XM; HASHIMOTO T; TAMMINGA CA
      PHENCYCLIDINE (PCP) AND DIZOCILPINE (MK801) EXERT TIME-DEPENDENT EFFECTS ON THE EXPRESSION OF IMMEDIATE-EARLY GENES IN RAT-BRAIN

      Synapse
    44. LAHTI AC; WEILER M; CARLSSON A; TAMMINGA CA
      EFFECTS OF THE D-3 AND AUTORECEPTOR-PREFERRING DOPAMINE ANTAGONIST (-UH232 IN SCHIZOPHRENIA())

      Journal of neural transmission
    45. LAHTI RA; COCHRANE EV; ROBERTS RC; CONLEY RR; TAMMINGA CA
      [H-3]NEUROTENSIN RECEPTOR DENSITIES IN HUMAN POSTMORTEM BRAIN-TISSUE OBTAINED FROM NORMAL AND SCHIZOPHRENIC PERSONS - AN AUTORADIOGRAPHIC STUDY

      Journal of neural transmission
    46. TAMMINGA CA; BUCHANAN RW; GOLD JM
      THE ROLE OF NEGATIVE SYMPTOMS AND COGNITIVE DYSFUNCTION IN SCHIZOPHRENIA OUTCOME

      International clinical psychopharmacology
    47. CHAKOS MH; SHIRAKAWA O; LIEBERMAN J; LEE H; BILDER R; TAMMINGA CA
      STRIATAL ENLARGEMENT IN RATS CHRONICALLY TREATED WITH NEUROLEPTIC

      Biological psychiatry
    48. TAMMINGA CA
      SEROTONIN AND SCHIZOPHRENIA

      Biological psychiatry
    49. LAHTI AC; WEILER MA; COREY PK; LAHTI RA; CARLSSON A; TAMMINGA CA
      ANTIPSYCHOTIC PROPERTIES OF THE PARTIAL DOPAMINE AGONIST (-)-3-(3-HYDROXYPHENYL)-N-N-PROPYLPIPERIDINE (PRECLAMOL) IN SCHIZOPHRENIA

      Biological psychiatry
    50. TAMMINGA CA
      ASKING QUESTIONS ABOUT PSYCHOSIS PATHOPHYSIOLOGY - IN RATS WITH PCP AND IN HUMANS

      Biological psychiatry
    51. HOLCOMB HH; LAHTI AC; MEDOFF DR; WEILER M; TAMMINGA CA
      TONE RECOGNITION RESPONSE-TIME AND CEREBRAL BLOOD-FLOW - NV AND SZ

      Biological psychiatry
    52. TAMMINGA CA
      BRAIN DEVELOPMENT, VI - RADIAL MIGRATION AND CORTICAL EVOLUTION

      The American journal of psychiatry
    53. ZIMBROFF DL; KANE JM; TAMMINGA CA
      SERTINDOLE VERSUS HALOPERIDOL FOR SCHIZOPHRENIA - DR. ZIMBROFF AND COLLEAGUES REPLY

      The American journal of psychiatry
    54. TAMMINGA CA
      BRAIN-DEVELOPMENT, V - EXPERIENCE AFFECTS BRAIN-DEVELOPMENT

      The American journal of psychiatry
    55. TAMMINGA CA
      BRAIN-DEVELOPMENT, IV - AXON ROUTING AND REROUTING

      The American journal of psychiatry
    56. CONLEY RR; TAMMINGA CA; BARTKO JJ; RICHARDSON C; PESZKE M; LINGLE J; HEGERTY J; LOVE R; GOUNARIS C; ZAREMBA S
      OLANZAPINE COMPARED WITH CHLORPROMAZINE IN TREATMENT-RESISTANT SCHIZOPHRENIA

      The American journal of psychiatry
    57. TAMMINGA CA
      BRAIN-DEVELOPMENT, III - CEREBRAL-CORTEX

      The American journal of psychiatry
    58. TAMMINGA CA
      CLINICAL GENETICS, VII - POSITIONAL CANDIDATE GENE DISCOVERY FROM LINKAGE FINDINGS

      The American journal of psychiatry
    59. HASHIMOTO T; ROSS DE; GAO XM; MEDOFF DR; TAMMINGA CA
      MIXTURE IN THE DISTRIBUTION OF HALOPERIDOL-INDUCED ORAL DYSKINESIAS IN THE RAT SUPPORTS AN ANIMAL-MODEL OF TARDIVE-DYSKINESIA

      Psychopharmacology
    60. WARFEL DT; LAHTI AC; COREY T; WEILER MA; MEDOFF D; TAMMINGA CA
      SYMPTOMS CLUSTER-ANALYSIS ON AND OFF NEUROLEPTIC MEDICATION

      Schizophrenia research
    61. KELLEY JJ; GAO XM; TAMMINGA CA; ROBERTS RC
      THE EFFECT OF CHRONIC HALOPERIDOL TREATMENT ON DENDRITIC SPINES IN THE RAT STRIATUM

      Schizophrenia research
    62. LAHTI RA; ROBERTS RC; COCHRANE EV; TAMMINGA CA
      [H-3] NEUROTENSIN RECEPTOR LEVELS IN HUMAN POSTMORTEM BRAIN - COMPARISON OF NORMALS TO SCHIZOPHRENICS OFF-ANTIPSYCHOTIC, OR ON-ANTIPSYCHOTIC DRUGS AT DEATH

      Schizophrenia research
    63. LAHTI RA; ROBERTS RC; COCHRANE EV; PRIMUS RJ; GALLAGER DW; TAMMINGA CA
      [H-3] NGD-94-1 BINDING IN HUMAN POSTMORTEM BRAIN OF NORMALS AND SCHIZOPHRENICS OFF-ANTIPSYCHOTIC, OR ON-ANTIPSYCHOTIC DRUGS AT DEATH

      Schizophrenia research
    64. SCHWARCZ R; WU HQ; RASSOULPOUR A; TAMMINGA CA; MEDOFF DR; ROBERTS RC
      POSTMORTEM DETERMINATION OF KYNURENINE AND KYNURENIC ACID LEVELS IN THE BRAINS OF SCHIZOPHRENIC-PATIENTS

      Schizophrenia research
    65. GAO XM; CHEN LW; TAMMINGA CA
      BLOCKADE OF PHENCYCLIDINE-INDUCED AND MK801-INDUCED REGIONAL ZIF268 MESSENGER-RNA EXPRESSION

      Schizophrenia research
    66. LAHTI RA; TAMMINGA CA
      THE EFFECTS OF AMPHETAMINE, ALPHA-MPT, AND ANTIPSYCHOTICS ON DOPAMINED2 RECEPTOR OCCUPANCY - AN EEDQ STUDY

      Schizophrenia research
    67. COREY PK; LAHTI AC; LAPORTE DJ; WEILER MA; WARFEL DT; TAMMINGA CA
      THE EFFECTS OF KETAMINE ON MEMORY AND OTHER COGNITIVE FUNCTIONS IN SCHIZOPHRENIC-PATIENTS AND NORMAL VOLUNTEERS

      Schizophrenia research
    68. HOLCOMB HH; CHEN LW; LAHTI A; ZHAO Z; MEDOFF D; CAUDILL PJ; WEILER M; TAMMINGA CA
      RESPONSE-TIME (RT) AND THE ODDS OF MAKING A CORRECT CHOICE

      Schizophrenia research
    69. LAPORTE DJ; COREY PK; LAHTI AC; TAMMINGA CA
      COMPARISON OF HIPPOCAMPAL TEST-PERFORMANCE IN SCHIZOPHRENIC INPATIENTS STABILIZED WITH TYPICAL ANTIPSYCHOTIC MEDICATION AND MEDICATION FREE

      Schizophrenia research
    70. THOROUGHMAN KA; WEILER MA; LAHTI AC; TAMMINGA CA; HOLCOMB HH
      IMPLICIT MOTOR LEARNING AND MEMORY IN SCHIZOPHRENIA

      Schizophrenia research
    71. SJODIN LE; ROSS DE; VLADAR K; BUCHANAN RW; THAKER GK; HOLCOMB HH; TAMMINGA CA
      COMPARISON OF STRIATAL VOLUMES IN SCHIZOPHRENIC-PATIENTS WITH AND WITHOUT EYE TRACKING DISORDER

      Schizophrenia research
    72. CHEN LW; ZHAO Z; MEDOFF D; HOLCOMB HH; LAHTI AC; TAMMINGA CA
      HOW MANY SUBJECTS - A MONTE-CARLO BOOTSTRAP SIMULATION FOR FUNCTIONALIMAGING

      Schizophrenia research
    73. HOLCOMB HH; LAHTI A; MEDOFF D; ZHAO Z; WEILER M; COREY P; WARFEL D; TAMMINGA CA
      KETAMINE INDUCED CEREBELLAR-CINGULATE RCBF CORRELATIONS AND RCBF PATTERNS IN NORMAL VOLUNTEERS (NV) AND SCHIZOPHRENIC-PATIENTS (SZ)

      Schizophrenia research
    74. LAHTI AC; HOLCOMB HH; CARPENTER WT; ZHAO M; BUCHANAN RW; TAMMINGA CA
      BLOOD-FLOW ACTIVATION DIFFERENCES DURING AN AUDITORY TASK IN SCHIZOPHRENIC-PATIENTS WITH AND WITHOUT PRIMARY NEGATIVE SYMPTOMS

      Schizophrenia research
    75. LAHTI AC; HOLCOMB HH; WEILER MA; ZHAO M; MEDOFF D; CHEN LW; TAMMINGA CA
      REGIONAL CORRELATIONS BETWEEN KETAMINE-INDUCED ACTIONS ON PSYCHOSIS AND REGIONAL CEREBRAL BLOOD-FLOW (RCBF)

      Schizophrenia research
    76. MEDOFF DR; HOLCOMB HH; LAHTI AC; ZHAO Z; CHEN LW; TAMMINGA CA
      THE METHODOLOGICAL EFFECTS OF REPEATED [15]O PET BLOOD-FLOW SCANS IN SCHIZOPHRENIC AND NORMAL VOLUNTEERS DURING REST AND TASK-PERFORMANCE

      Schizophrenia research
    77. ROSS DE; HOLCOMB HH; THAKER GK; BUCHANAN R; MEDOFF DR; TAMMINGA CA
      FUNCTIONAL NEUROANATOMY OF SMOOTH-PURSUIT EYE-MOVEMENTS IN NORMAL CONTROLS AND SCHIZOPHRENIC-PATIENTS

      Schizophrenia research
    78. ZHAO Z; HOLCOMB HH; LAHTI AC; CHEN LW; MEDOFF D; TAMMINGA CA
      KETAMINE INDUCED TIME EFFECT BY PRINCIPAL COMPONENT ANALYSIS

      Schizophrenia research
    79. CONLEY RR; TAMMINGA CA; BEASLEY C
      OLANZAPINE VS CHLORPROMAZINE IN THERAPY-REFRACTORY SCHIZOPHRENIA

      Schizophrenia research
    80. LAHTI AC; LAHTI RA; CARLSSON A; TAMMINGA CA
      THE TREATMENT OF SCHIZOPHRENIA WITH PARTIAL DOPAMINE AGONIST - A PROMISING STRATEGY

      Schizophrenia research
    81. WEILER MA; THAKER GK; LAHTI AC; ROSS DE; TAMMINGA CA
      EFFECTS OF KETAMINE ON EYE TRACKING IN SCHIZOPHRENIA AND CONTROLS

      Schizophrenia research
    82. GAO XM; SAKAI K; TAMMINGA CA
      CHRONIC TREATMENT OF RATS WITH SERTINDOLE AND OLANZAPINE PRODUCE LOW RATES OF ORAL DYSKINESIAS

      Schizophrenia research
    83. SAKAI K; GAO XM; TAMMINGA CA
      NEUROCHEMICAL ACTIONS OF TYPICAL AND ATYPICAL NEUROLEPTICS IN BASAL GANGLIA AND THALAMUS

      Schizophrenia research
    84. TAMMINGA CA
      THE PROMISE OF NEW DRUGS FOR SCHIZOPHRENIA TREATMENT

      Canadian journal of psychiatry
    85. PANDEY GN; DWIVEDI Y; PANDEY SC; CONLEY RR; ROBERTS RC; TAMMINGA CA
      PROTEIN-KINASE-C IN THE POSTMORTEM BRAIN OF TEENAGE SUICIDE VICTIMS

      Neuroscience letters
    86. GAO XM; HASHIMOTO T; COOPER TB; TAMMINGA CA
      THE DOSE-RESPONSE CHARACTERISTICS OF RAT ORAL DYSKINESIAS WITH CHRONIC HALOPERIDOL OR CLOZAPINE ADMINISTRATION

      Journal of neural transmission
    87. TAMMINGA CA; MACK RJ; GRANNEMAN GR; SILBER CJ; KASHKIN KB
      SERTINDOLE IN THE TREATMENT OF PSYCHOSIS IN SCHIZOPHRENIA - EFFICACY AND SAFETY

      International clinical psychopharmacology
    88. MAEDA K; KANEDA H; WHETSELL WO; TAMMINGA CA
      NEUROCHEMICAL AND METABOLIC CONSEQUENCES OF ELEVATED CEREBROSPINAL-FLUID QUINOLINIC ACID CONCENTRATIONS IN RAT-BRAIN

      Neuroscience research
    89. PANDEY GN; CONLEY RR; PANDEY SC; GOEL S; ROBERTS RC; TAMMINGA CA; CHUTE D; SMIALEK J
      BENZODIAZEPINE RECEPTORS IN THE POSTMORTEM BRAIN OF SUICIDE VICTIMS AND SCHIZOPHRENIC SUBJECTS

      Psychiatry research
    90. CASSADY SL; THAKER GK; SUMMERFELT A; TAMMINGA CA
      THE MARYLAND-PSYCHIATRIC-RESEARCH-CENTER SCALE AND THE CHARACTERIZATION OF INVOLUNTARY MOVEMENTS

      Psychiatry research
    91. TAMMINGA CA
      GENDER AND SCHIZOPHRENIA

      The Journal of clinical psychiatry
    92. TAMMINGA CA; CONLEY RR
      THE APPLICATION OF NEUROIMAGING TECHNIQUES TO DRUG DEVELOPMENT

      The Journal of clinical psychiatry
    93. CONLEY RR; TAMMINGA CA
      OLANZAPINE VS. CHLORPROMAZINE IN TREATMENT-RESISTANT SCHIZOPHRENIA

      Psychopharmacology bulletin
    94. KELLEY JJ; GAO XM; TAMMINGA CA; ROBERTS RC
      THE EFFECT OF CHRONIC HALOPERIDOL TREATMENT ON DENDRITIC SPINES IN THE RAT STRIATUM

      Experimental neurology
    95. LAHTI AC; HOLCOMB HH; WEILER MA; COREY PK; ZHAO M; MEDOFF D; TAMMINGA CA
      EFFECTS OF KETAMINE ON BEHAVIOR AND RCBF IN SCHIZOPHRENIC AND NORMAL INDIVIDUALS

      Biological psychiatry
    96. LAHTI AC; HOLCOMB HH; CARPENTER WT; ZHAO M; WEILER MA; COREY PK; MEDOFF D; BUCHANAN RW; TAMMINGA CA
      RCBF PATTERN DIFFERENCES BETWEEN DEFICIT AND NONDEFICIT SCHIZOPHRENIC-PATIENTS

      Biological psychiatry
    97. CONLEY RR; TAMMINGA CA; BEASLEY C
      OLANZAPINE VS CHLORPROMAZINE IN TREATMENT-RESISTANT SCHIZOPHRENIA

      Biological psychiatry
    98. CONLEY RR; CARPENTER WT; TAMMINGA CA
      TIME TO CLOZAPINE RESPONSE IN A STANDARDIZED TRIAL

      The American journal of psychiatry
    99. TAMMINGA CA; SCHWARCZ R; MACDONALD ME
      HUNTINGTONS-DISEASE - FROM DISEASE TO GENE

      The American journal of psychiatry
    100. ZIMBROFF DL; KANE JM; TAMMINGA CA; DANIEL DG; MACK RJ; WOZNIAK PJ; SEBREE TB; WALLIN BA; KASHKIN KB; ADAN F; AINSLIE G; ALLAN E; ATRI P; BAKER R; BEITMAN B; BROWN G; CANIVE J; CARMAN J; DOTT S; EDWARDS J; FENTON W; FREIDLI J; FUNDERBURG L; ERESHEFSKY L; GLADSON M; HAMILTON J; HAQUE S; HARTFORD J; HORNE R; HOUCK C; JAMPALA C; LABELLE A; LARSON G; LESEM M; LISKOW B; MAKELA E; MOORE N; MORPHY M; POSEVER T; RISCH S; ROTROSEN J; SHEEHAN D; SILVERSTONE P; SWANN A; TAPP A; THOMAS M; VOLAVKA J; VORA S
      CONTROLLED, DOSE-RESPONSE STUDY OF SERTINDOLE AND HALOPERIDOL IN THE TREATMENT OF SCHIZOPHRENIA

      The American journal of psychiatry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/01/21 alle ore 06:03:25